Friedenthal Financial: VCLT position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Friedenthal Financial on VCLT, newest first. How the timeline and the estimate are built.
Friedenthal Financial held 527 VCLT shares at 2026-06-30 per its 13F-HR filed 2026-07-13.
the latest 13F is the newest step
- period ended2026-06-3013F 527 sharesChange vs previous 13F +38 shares
0.02% of the 13F portfolio, value $39,657.
13F-HR 0001598611-26-000004 filed by Friedenthal Financial
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 489 sharesChange vs previous 13F +21 shares
0.02% of the 13F portfolio, value $36,539.
13F-HR 0001598611-26-000003 filed by Friedenthal Financial
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 468 sharesChange vs previous 13F +159 shares
0.02% of the 13F portfolio, value $35,498.
13F-HR 0001598611-26-000001 filed by Friedenthal Financial
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 309 sharesChange vs previous 13F +5 shares
0.01% of the 13F portfolio, value $23,994.
13F-HR 0001598611-25-000007 filed by Friedenthal Financial
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 304 sharesChange vs previous 13F 0 shares
0.01% of the 13F portfolio, value $23,074.
13F-HR 0001598611-25-000006 filed by Friedenthal Financial
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 304 sharesChange vs previous 13F not available
0.01% of the 13F portfolio, value $23,077.
13F-HR 0001598611-25-000004 filed by Friedenthal Financial
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).